• Global RSV Diagnostics Market Projected to Grow at a CAGR of 9.4%

    According to a newly published market research report by 24LifeSciences, global RSV diagnostics market was valued at USD 795 million in 2025 and is projected to grow from USD 870 million in 2026 to reach USD 1,470 million by 2034, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period.

    Respiratory Syncytial Virus (RSV) diagnostics encompass the critical tests and methods used to detect the presence of the virus, a leading cause of severe lower respiratory tract infections worldwide. Primarily affecting vulnerable populations such as infants, young children, and older adults, these diagnostics include rapid antigen detection tests (RADTs), molecular assays like PCR, and viral culture techniques, each offering different levels of speed and specificity for clinical decision-making in both hospital and outpatient settings.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9340/rsv-diagnostics-market
    Global RSV Diagnostics Market Projected to Grow at a CAGR of 9.4% According to a newly published market research report by 24LifeSciences, global RSV diagnostics market was valued at USD 795 million in 2025 and is projected to grow from USD 870 million in 2026 to reach USD 1,470 million by 2034, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period. Respiratory Syncytial Virus (RSV) diagnostics encompass the critical tests and methods used to detect the presence of the virus, a leading cause of severe lower respiratory tract infections worldwide. Primarily affecting vulnerable populations such as infants, young children, and older adults, these diagnostics include rapid antigen detection tests (RADTs), molecular assays like PCR, and viral culture techniques, each offering different levels of speed and specificity for clinical decision-making in both hospital and outpatient settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9340/rsv-diagnostics-market
    0 Commentarii 0 Distribuiri 96 Views 0 previzualizare
  • Top 10 Players Shaping the Global Hepatitis E Diagnostic Tests Market (2026–2034)

    According to a newly published market research report by 24LifeSciences, global Hepatitis E Diagnostic Tests market is valued at USD 40.1 million in 2026 and is projected to reach USD 47.1 million by 2034, growing at a compound annual growth rate (CAGR) of 2.4% during the forecast period.

    Hepatitis E diagnostic tests are critical medical tools designed to detect the presence of the Hepatitis E Virus (HEV), an RNA virus responsible for acute liver inflammation. These tests are indispensable for confirming infection, particularly during outbreaks and for high-risk populations such as pregnant women, immunocompromised individuals, and patients with pre-existing liver conditions. The primary diagnostic methodologies include Enzyme-Linked Immunosorbent Assay (ELISA) kits, which identify IgM and IgG antibodies, and advanced molecular techniques like Reverse Transcription-Polymerase Chain Reaction (RT-PCR) tests that detect viral RNA directly, offering high specificity and sensitivity.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9474/hepatitis-e-diagnostic-tests-market
    Top 10 Players Shaping the Global Hepatitis E Diagnostic Tests Market (2026–2034) According to a newly published market research report by 24LifeSciences, global Hepatitis E Diagnostic Tests market is valued at USD 40.1 million in 2026 and is projected to reach USD 47.1 million by 2034, growing at a compound annual growth rate (CAGR) of 2.4% during the forecast period. Hepatitis E diagnostic tests are critical medical tools designed to detect the presence of the Hepatitis E Virus (HEV), an RNA virus responsible for acute liver inflammation. These tests are indispensable for confirming infection, particularly during outbreaks and for high-risk populations such as pregnant women, immunocompromised individuals, and patients with pre-existing liver conditions. The primary diagnostic methodologies include Enzyme-Linked Immunosorbent Assay (ELISA) kits, which identify IgM and IgG antibodies, and advanced molecular techniques like Reverse Transcription-Polymerase Chain Reaction (RT-PCR) tests that detect viral RNA directly, offering high specificity and sensitivity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9474/hepatitis-e-diagnostic-tests-market
    0 Commentarii 0 Distribuiri 159 Views 0 previzualizare
Abistem https://abistem.com